This document outlines details of PBS-subsidised mecasermin for patients with severe growth failure with primary insulin-like growth factor-1 deficiency (IGFD).
For details on how to process a PBS Authority, see Processing Complex Authority Required Listings.
Severe growth failure with primary IGFD quick reference
Restrictions | Authority level and section | PA assessment | Processing system | Prescriber type | Prescriber self-serve |
Initial PB336 form | Written Electronic S100: mecasermin | No | OPA | Must be treated and prescribed by a: - specialist in paediatric endocrinology
- paediatrician in consultation with a specialist in paediatric endocrinology
| Yes |
Continuing PB337 form | Written Electronic S100: mecasermin | No | OPA | Must be treated and prescribed by a: - specialist in paediatric endocrinology
- paediatrician in consultation with a specialist in paediatric endocrinology
| Yes |
Expand all